Cochlear stock rises on FY26 profit and ASX strength
Published on 09/03/2026 at 19:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cochlear stock (ISIN AU000000COH5) traded at AUD 136.45 on the ASX and was up 3.34 percent, while market capitalization stood at AUD 5.51 billion as of July 31, 2026, according to Yahoo Finance and Investing.com data. The latest reporting season backdrop is clear: FY26 underlying profit fell 22 percent to AUD 322.4 million, but management still expects FY27 profit of AUD 330 million to AUD 350 million, as Roger Montgomery wrote on September 3, 2026.
FY26 sets the tone
The profit figure matters because it came with a concrete comparison: FY26 underlying profit was 22 percent lower than the prior year, yet the FY27 outlook still points to a range of AUD 330 million to AUD 350 million. That puts the next twelve months at the center of the debate for Cochlear stock.
Market data also shows a tight valuation frame. Yahoo Finance listed a trailing price-to-earnings ratio of 22.87 and a forward price-to-earnings ratio of 22.94 as of July 31, 2026, alongside a revenue base of USD 2.34 billion and net income of USD 345.3 million on a trailing basis.
Trading around the range
On the chart side, the share price of AUD 136.45 sat between a 52-week low of AUD 31.82 and a 52-week high of AUD 104.65 in the quoted OTC snapshot, which underlines how different listing views can diverge from the local ASX price picture. The same Yahoo Finance page showed a 5.51 billion USD market cap as of July 31, 2026 and a forward dividend yield of 3.39 percent.
For investors, the key contrast is simple: Cochlear stock is supported by a large installed base and recurring upgrade economics, but the most recent reported profit line was weaker than the previous year. The market is therefore weighing the FY26 dip against the FY27 guide.
The product engine
The company describes itself as a provider of implantable hearing solutions, including cochlear implant systems, sound processor upgrades, bone conduction systems and accessories. That product mix is the reason the FY26 profit figure still carries weight for the stock, because upgrades and replacement cycles can soften the impact of one weaker year.
Price and market view
Cochlear stock last traded at AUD 136.45 on the ASX-linked snapshot, with a session move of plus 1.56 percent on the Investing.com AU quote page and plus 3.34 percent on Yahoo Finance's OTC view as of September 3, 2026. The gap between those snapshots shows why the local market level and the quoted overseas line both matter when reading the stock.
Cochlear at a glance
- Company: Cochlear Limited
- ISIN: AU000000COH5
- Ticker: COH
- Trading venue: ASX
- Price (as of September 3, 2026): AUD 136.45
- Market capitalization: AUD 5.51 billion (as of July 31, 2026)
- Sector / Industry: Healthcare / Medical Devices
- Index membership: S&P/ASX 200
